Zoetis Inc. (ZTS)
Pharmaceutical Preparations · Pharmaceutical Preparations · NYSE
$73.96
+1.36%
Investingg Score
55.6 / 100
Hold
Business overview
- Free cash flow margin of 24.1 percent indicates strong cash generation relative to revenue.
- Operating margin data is unavailable in the provided dataset.
- Gross margin data is unavailable in the provided dataset.
Strong cash conversion supports the operational foundation, though the lack of margin details creates uncertainty regarding core profitability.
Financial health
- Balance sheet pillar score stands at 41, indicating moderate balance sheet strength.
- Market capitalization is 31427640488.6 dollars, reflecting a large-scale enterprise.
- Additional direct debt and liquidity metrics are unavailable in the provided dataset.
The moderate balance sheet score alongside a large market cap suggests stability, but limited data prevents a complete financial health assessment.
- Gross Margin
- Data unavailable
- Operating Margin
- Data unavailable
- Current Ratio
- 3.0x
- Debt / Equity
- 2.71
- Free Cash Flow (TTM)
- $2.3B
- Interest Coverage
- Data unavailable
Valuation
- P/E ratio is 11.51, suggesting an attractive valuation relative to earnings.
- P/S ratio is 3.28, providing a reasonable price per dollar of sales.
- Free cash flow yield is 7.3 percent, pointing to efficient cash returns.
Together, these favorable valuation multiples suggest the stock may be underpriced relative to its earnings and cash generation.
- P/E (TTM)
- 11.5x
- Forward P/E
- Data unavailable
- Price / Sales
- 3.3x
- EV / EBITDA
- Data unavailable
- FCF Yield
- 7.3%
Key risks
- Severe technical downtrend with price sitting 30.4 percent below the 200-day moving average.
- Low growth pillar score of 31 driven by modest 2.3 percent year-over-year revenue growth.
- Data unavailable for gross margin and operating margin, limiting profitability visibility.
Market cap $31.4B · data as of 2026-08-18
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze ZTS with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.